Biogen Inc. is upgraded to 'Buy' as strategic acquisitions and pipeline progress offset multiple sclerosis portfolio erosion.
Geographic atrophy (GA), secondary to age-related macular degeneration (AMD), remains one of the most challenging conditions ...
K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s further evaluation.
The US Food and Drug Administration (FDA) has updated 17 draft product-specific guidances (PSGs) to assist sponsors in submitting abbreviated new drug applications (ANDAs) for injectable peptide ...
Pegcetacoplan slows photoreceptor and retinal pigment epithelium loss in patients with geographic atrophy only as well as patients with GA and concurrent wet age-related macular degeneration, ...
Pegcetacoplan may help slow visual acuity loss in patients with geographic atrophy, according to a study presented at the ...
Belite Bio (BLTE) is positioned for upside with tinlarebant, an oral therapy for Stargardt disease, following a successful ...
New Scientist on MSN
Eye implant that restores vision lost to age approved for use
An eye implant and a pair of high-tech glasses that enable people with a severe form of vision loss to read have been ...
Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by ...
Jordana Fein, MD, MS, presented 64-week QUASAR data showing aflibercept 8 mg sustained visual acuity gains with up to 3 fewer injections than aflibercept 2 mg in macular edema following RVO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results